Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Ridgewood, N.J.-based Valley Health System expanded its relationship with Excelerate, a strategic health sourcing company that relies on evidence-based clinical outcomes to select medical products.
Wal-Marts on Tuesday shared plans to update its mobile app and streamline pharmacy processes for customers, reports Market Watch.
Household appliances that generate electric and magnetic fields may cause pacemakers to malfunction, according to a study published Monday in Circulation.
The Food and Drug Administration approved a record-high amount of generic drugs last year.
New Brunswick, N.J.-based Johnson & Johnson on Monday released a report detailing price increases for its prescription drugs, reports CNBC.
The Food and Drug Administration approved Nesher Pharmaceuticals' oseltamivir phosphate capsules, reports Business Standard.
Boston Children's Hospital will serve as one of 24 test sites in the U.S. for a Phase 3 clinical trial of Santhera Pharmaceuticals' experimental drug for Duchenne muscular dystrophy, reports The Boston Globe.
Paris-based Sanofi will enter into a joint venture with the Swiss drug manufacturer Lonza to open a $285 million biologics facility by 2020, reports Reuters.
While drugmakers typically raise list prices in January, many companies scaled back price hikes amid rising scrutiny over the cost of prescription drugs, reports The Wall Street Journal.
Nilesh Gupta, managing director of Lupin Pharmaceuticals, warned a potential border tax in the U.S. could be highly disruptive for Indian drug manufacturing companies, reports BloombergQuint.